Disc Medicine Files 8-K, Formerly Gemini Therapeutics

Ticker: IRON · Form: 8-K · Filed: Jun 14, 2024 · CIK: 1816736

Disc Medicine, Inc. 8-K Filing Summary
FieldDetail
CompanyDisc Medicine, Inc. (IRON)
Form Type8-K
Filed DateJun 14, 2024
Risk Levellow
Pages5
Reading Time6 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: corporate-filing, name-change

TL;DR

Disc Medicine (formerly Gemini) filed a standard 8-K, no new news.

AI Summary

Disc Medicine, Inc. filed an 8-K on June 14, 2024, to report on other events and financial statements. The company was formerly known as Gemini Therapeutics, Inc. and FS Development Corp. before name changes on February 9, 2021, and July 2, 2020, respectively. The filing is primarily procedural and does not disclose new material events.

Why It Matters

This filing serves as a procedural update and confirms the company's identity and history, which is important for investors tracking corporate changes.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for corporate record-keeping and does not contain new material information that would impact risk.

Key Numbers

  • 20240614 — Filing Date (Date of the 8-K filing)
  • 20210209 — Name Change Date (Date Disc Medicine changed from Gemini Therapeutics, Inc.)
  • 20200702 — Name Change Date (Date Disc Medicine changed from FS Development Corp.)

Key Players & Entities

  • Disc Medicine, Inc. (company) — Registrant
  • Gemini Therapeutics, Inc. (company) — Former company name
  • FS Development Corp. (company) — Former company name
  • 0001816736 (company) — Central Index Key
  • 001-39438 (company) — SEC File Number

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose is to report on 'Other Events' and 'Financial Statements and Exhibits' as per SEC regulations, and to update corporate information.

When did Disc Medicine, Inc. change its name from Gemini Therapeutics, Inc.?

Disc Medicine, Inc. changed its name from Gemini Therapeutics, Inc. on February 9, 2021.

What was the company's name before Gemini Therapeutics, Inc.?

Before being Gemini Therapeutics, Inc., the company was named FS Development Corp., with a name change date of July 2, 2020.

What is the company's principal executive office address?

The company's principal executive office is located at 321 Arsenal Street, Suite 101, Watertown, Massachusetts 02472.

What is the SIC code for Disc Medicine, Inc.?

The Standard Industrial Classification (SIC) code for Disc Medicine, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 1,452 words · 6 min read · ~5 pages · Grade level 12.6 · Accepted 2024-06-14 07:36:01

Key Financial Figures

  • $0.0001 — ich registered Common Stock, par value $0.0001 per share IRON The Nasdaq Global Ma

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DISC MEDICINE, INC. Date: June 14, 2024 By: /s/ John Quisel Name: John Quisel, J.D., Ph.D. Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.